Analysed RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ) News Sources
Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference
06-05-2026
yahoo.com
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
08-05-2026
yahoo.com
Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology
12-05-2026
yahoo.com
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
26-05-2026
yahoo.com
Rhythm Pharmaceuticals Announces Publication of New Bardet-Biedl Syndrome Diagnostic Algorithm in the American Journal of Medical Genetics
28-05-2026
yahoo.com
Rhythm Pharmaceuticals Announces Seven Abstracts Accepted for Presentation at ENDO 2026
29-05-2026
yahoo.com
How Investors May Respond To Rhythm Pharmaceuticals (RYTM) Updating Its Bardet-Biedl Diagnosis Algorithm
08-06-2026
yahoo.com
Rhythm Pharmaceuticals to Announce Interim Six-Month Phase 2 Results Evaluating Setmelanotide in Patients with Prader-Willi Syndrome
12-06-2026
yahoo.com
What is the current price of RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ)?
The current price of RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ) is $88.4.
RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ) absolute price change since previous trading day?
The absolute price change of RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ) since the previous trading day is $0.74.
RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ) percentage price change since previous trading day?
The percentage price change of RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ) since the previous trading day is 0.8442%.
What is the most recent average sentiment score for RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ)?
The most recent average sentiment score for RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ)?
The most recent sentiment for RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ) is .
SEC-8K** Filing Available For RHYTHM PHARMACEUTICALS INC (RYTM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.